PTC Therapeutics (PTCT) is technically in oversold territory now, so the heavy selling pressure migh

The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre

Although the revenue and EPS for PTC Therapeutics (PTCT) give a sense of how its business performed

PTC Therapeutics, Inc. (PTCT) Q2 2026 Earnings Call Transcript

PTC Therapeutics (PTCT) came out with quarterly earnings of $0.92 per share, beating the Zacks Conse

– Robust Q2 performance with total revenue of $361 million, including $239 million of product revenu

Fifth Third Bancorp increased its position in shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) by 12,

CONSHOHOCKEN, Pa., July 23, 2026 /PRNewswire/ -- Leading private markets investment management firm

Bessemer Group Inc. boosted its position in shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) by 21,81

Wells Fargo analyst Benjamin Burnett maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight a

WARREN, N.J., July 16, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today th

Cantor Fitzgerald analyst Kristen Kluska maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweig

The transaction generated $222,376 in gross proceeds, realized through the exercise of 2,464 options

PTCT's rare disease portfolio expands as Sephience sales surge, while late-stage pipeline programs a

Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market l

PTC Therapeutics (PTCT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimi

Catalyst Pharmaceuticals' Agamree matches Emflaza's glucocorticoid activity while showing less immun

PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher th

WARREN, N.J., June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced th

PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes

– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible n

– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity – – Offe

PTC Therapeutics, Inc. (PTCT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 202

Royalty Pharma has acquired PTC's remaining royalty on Roche's Evrysdi for $240 million upfr

https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnin

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Fo

Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its f

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f

Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for